Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice
This is not a rural footnote
Standard administration involves daily subcutaneous injection, typically 2 mg, delivered in the abdominal area on an empty stomach
Weight loss through Ro combines GLP-1 medications (if appropriate) with personalized clinical care, including monthly check-ins, unlimited messaging, health coaching, and tools for lasting lifestyle changes
By persistently activating GLP-1 receptors, these drugs provide a constant signal of fullness to the brain, leading to a significant reduction in calorie intake and subsequent weight loss